APA (7th ed.) Citation

Uluk, D., Pein, J., Herda, S., Schliephake, F., Schneider, C. V., Bitar, J., . . . Lurje, G. (2025). Metabolic dysfunction-associated steatotic liver disease (MASLD) impacts long-term outcomes after curative-intent surgery for hepatocellular carcinoma: Original article. Alimentary pharmacology & therapeutics, 61(8), . https://doi.org/10.1111/apt.70002

Chicago Style (17th ed.) Citation

Uluk, Deniz, et al. "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Impacts Long-term Outcomes After Curative-intent Surgery for Hepatocellular Carcinoma: Original Article." Alimentary Pharmacology & Therapeutics 61, no. 8 (2025). https://doi.org/10.1111/apt.70002.

MLA (9th ed.) Citation

Uluk, Deniz, et al. "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) Impacts Long-term Outcomes After Curative-intent Surgery for Hepatocellular Carcinoma: Original Article." Alimentary Pharmacology & Therapeutics, vol. 61, no. 8, 2025, https://doi.org/10.1111/apt.70002.